Publications by authors named "Toru Kitazawa"

Claim this Profile
I
Impact of Preoperative Diabetes on Insulin Management and Nutritional Status After Total or Completion Pancreatectomy.
Tomotaka Kato, Yoshihiro Ono, Toru Kitazawa, Kosuke Kobayashi, Atsushi Oba

Ann Surg Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Diabetic and Nutritional Management After Total or Completion Pancreatectomy: Current Status and Future Perspectives.
Tomotaka Kato, Yoshihiro Ono, Toru Kitazawa, Kosuke Kobayashi, Atsushi Oba

Ann Surg Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol: The effect of a low-carbohydrate enteral nutrition formula on postoperative hyperglycemia in non-diabetic patients with esophageal cancer: A randomized exploratory phase II trial (ENLICHE study).
Masayoshi Terayama, Yu Imamura, Toru Kitazawa, Naoki Miyazaki, Misuzu Ishii

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study).
Hitoshi Ishii, Nozomu Kamei, Dai Shimono, Tetsuji Niiya, Takahiro Tosaki, Toru Kitazawa

Diabetes Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24-week, open-label, controlled trial (STOP-OB).
Toru Kitazawa, Hiroaki Seino, Hiroshi Ohashi, Takeshi Inazawa, Masahiro Inoue

Diabetes Obes Metab· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR).
Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa, Yosuke Okada, Takamasa Ichijo

Cardiovasc Diabetol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy.
Hisamitsu Ishihara, Motonobu Anai, Hiroaki Seino, Toru Kitazawa, Hiroshi Ohashi

Diabetes Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy of glucagon-like peptide-1 receptor agonists and insulin for patients who developed diabetes after partial pancreatectomy.
Toru Kitazawa, Kazuhito Yokoyama, Ken Kubota

J Diabetes Investig· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale.
Takeshi Inazawa, Kentaro Sakamoto, Takahide Kohro, Raisuke Iijima, Toru Kitazawa

Lipids Health Dis· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study.
Yuichi Kojima, Hideyoshi Kaga, Shinu Hayashi, Toru Kitazawa, Yuko Iimura

World J Diabetes· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis